WebDec 5, 2015 · Carboplatin-etoposide combination therapy for NEC may have comparable effectiveness and milder adverse events than cisplatin-etoposide … WebRituximab (375 mg/m(2)) was given on day 1 and 3 of each cycle (day 1 only for cycle 3), with ifosfamide (3,000 mg/m(2)) and etoposide (100 mg/m(2)) given on days 3, 4, and 5 and carboplatin (635 mg/m(2)) given on day 3 only. Results: Twenty-one patients were enrolled, of whom 20 were eligible and evaluable. Although hematologic toxicities were ...
Carboplatin-etoposide combination chemotherapy in
WebChemotherapy has been the first-choice treatment for small-cell esophageal cancer (SCEC), etoposide plus cisplatin or carboplatin (EP/CP) is the most commonly recommended chemotherapeutical strategy. However, the choice of chemotherapy in treating SCEC has not been validated by studies of large coho … WebFeb 26, 2024 · In der IMpower 131 dagegen, die Chemotherapie vs. einer Chemo-Immuntherapie mit Atezolizumab prüfte, konnte kein OS-Unterschied gezeigt werden. ... (Carboplatin/Etoposid plus Atezolizumab) erzielt werden. Letztgenannte Kombination gilt als neuer Standard bei fortgeschrittener Erkrankung – die Zulassung wird erwartet. short sleeve cotton mock turtleneck
Erstlinientherapie des kleinzelligen Lungenkarzinoms (SCLC)
WebSep 28, 2024 · This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that … WebDec 14, 2024 · Die ZUMA-7-Studie ist die erste randomisierte Phase-III-Studie für eine autologe CD19-gerichtete CAR-T-Zell-Therapie. Beim diesjährigen Kongress der American Society of Hematology (ASH) wurden die Ergebnisse des Vergleichs von Axicabtagen-Ciloleucel versus Standardtherapien in der Plenarsitzung präsentiert. WebCarboplatin + Etoposide is a Chemotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC) How does carboplatin + etoposide work? Each of the chemotherapy medications in carboplatin + etoposide are designed to target and kill rapidly dividing lung cancer cells. Goals of therapy: san vincent of paul